title: Falls prevention focused medication review by a pharmacist in an acute hospital: implications for future practice.
abstract: BACKGROUND
  Patients at risk of falling are regularly prescribed medicines which increase falls risk. Medication review is a widely advocated risk reduction strategy.
  
  
  OBJECTIVE
  The objectives of this descriptive study were to determine the number and types of falls risk medicines suitable for intervention, and to develop guidance to optimise the effectiveness of future medication related falls prevention initiatives.
  
  
  METHODS
  An Irish acute teaching hospital and tertiary referral centre.
  
  
  METHODS
  50 hospital in-patients at risk of falls underwent medication review focused on falls prevention by a pharmacist. Falls risk medicines were identified, and reviewed. If scope to discontinue, dose reduce or switch to a safer alternative was identified by the pharmacist, the suggested medication changes were communicated to the patient's care team.
  
  
  METHODS
  Identification of the classes of falls risk medicines and types of prescriptions with greatest potential for intervention. Results The mean number of falls risk medicines prescribed to each patient was 4.8 (± 2.8) and the total number prescribed to the 50 patients was 238. Following medication review, the pharmacist identified 48 (20 %) as suitable for intervention. Consequently, 34 medication changes (70.8 %) were implemented. Four medication classes accounted for over 80 % of medication changes. These were anti-emetics, opioid analgesics, anti-cholinergic agents acting on the bladder and benzodiazepines/hypnotics. Intervention was statistically significantly more likely to be possible in the case of p.r.n. medicines compared to regular medicines (p < 0.001, Chi square test). Medication reviews focused on falls prevention took an average of 23.5 min per patient to complete.
  
  
  CONCLUSIONS
  Medication reviews focused on falls prevention involve striking a balance between minimising medicines associated with falls and effectively treating medical conditions. We found only 20 % of falls risk medicines were suitable for change, and reviews were time consuming and resource intensive. However, targeting four medication classes, and being particularly alert to the potential to discontinue 'as required' medicines, has the potential to achieve most of the benefits of more comprehensive reviews. This information will guide the development of future falls risk medicine review initiatives in our hospital, increasing their feasibility in the acute hospital setting.
authors.affiliation: Pharmacy Department, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland, clairebrowne1@gmail.com.
authors.forename: Claire
authors.initials: C
authors.lastname: Browne
authors.forename: Claire
authors.initials: C
authors.lastname: Kingston
authors.forename: Claire
authors.initials: C
authors.lastname: Keane
mesh_terms: D000058:Accidental Falls / Q000517:prevention & control*; D000368:Aged; D000369:Aged, 80 and over; D017723:Drug Utilization Review; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D057970:Inappropriate Prescribing / Q000517:prevention & control*; D008297:Male; D010595:Pharmacists; D010607:Pharmacy Service, Hospital; D010865:Pilot Projects; D024382:Professional Role
references.citation: BMC Geriatr. 2011 Nov 30;11:79
references.pmid: 22129458
references.citation: Am J Health Syst Pharm. 2003 May 15;60(10):1029-32
references.pmid: 12789875
references.citation: Arch Intern Med. 2011 Jun 13;171(11):1013-9
references.pmid: 21670370
references.citation: Br J Clin Pharmacol. 2009 Dec;68(6):936-47
references.pmid: 20002089
references.citation: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD005465
references.pmid: 20091578
references.citation: Br J Clin Pharmacol. 2007 Feb;63(2):232-7
references.pmid: 16939531
references.citation: Eur J Clin Pharmacol. 2011 Nov;67(11):1175-88
references.pmid: 21584788
references.citation: Age Ageing. 2008 Nov;37(6):673-9
references.pmid: 18829684
references.citation: Eur J Clin Pharmacol. 2011 Dec;67(12):1291-9
references.pmid: 21691806
references.citation: J Am Geriatr Soc. 2011 May;59(5):875-80
references.pmid: 21539525
references.citation: Drugs Aging. 2006;23(10):823-37
references.pmid: 17067185
references.citation: J Am Geriatr Soc. 1999 Jul;47(7):850-3
references.pmid: 10404930
references.citation: Age Ageing. 2006 Nov;35(6):586-91
references.pmid: 16905764
references.citation: Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007146
references.pmid: 19370674
references.citation: Drugs Aging. 2008;25(12):1021-31
references.pmid: 19021301
references.citation: Age Ageing. 2004 Jul;33(4):390-5
references.pmid: 15151914
references.citation: BMJ. 1997 Oct 25;315(7115):1049-53
references.pmid: 9366729
references.citation: Am J Geriatr Pharmacother. 2011 Oct;9(5):310-9.e2
references.pmid: 21925959